| 29.11.2024 13:00 | GDR | Block listing returns | RNS |
| 29.11.2024 10:56 | BOD, GDR, PEEL | AIM WINNERS & LOSERS: Botswana Diamonds shines; Peel Hunt slips | Alliance |
| 29.11.2024 10:18 | GDR | Genedrive annual loss widens due to increased expenses | Alliance |
| 29.11.2024 07:00 | GDR | Final Results | RNS |
| 22.11.2024 11:35 | PEEL, GDR, CPX | UK earnings, trading statements calendar - next 7 days | Alliance |
| 22.11.2024 07:00 | GDR | Notice of Results | RNS |
| 21.11.2024 11:06 | GDR | NIHR and OLS Funding Package | RNS |
| 05.11.2024 10:53 | GDR | Department for Business and Trade feature | Reach |
| 04.11.2024 13:29 | GDR | Scottish Health Technology Group publications | RNS |
| 21.10.2024 15:22 | GDR | Director Declaration | RNS |
| 15.08.2024 10:39 | GDR | Director/PDMR Shareholding | RNS |
| 12.08.2024 07:00 | GDR | First UK commercial sales of the CYP2C19-ID Kit | RNS |
| 06.08.2024 14:36 | GDR | Genedrive CEO leaves after less than a year; promotes CSO Miele to CEO | Alliance |
| 06.08.2024 07:00 | GDR | Directorate Change | RNS |
| 31.07.2024 11:33 | UKOG, CNR, GDR | AIM WINNERS & LOSERS: Genedrive gets UK CYP2C19-ID test boost | Alliance |
| 31.07.2024 07:00 | GDR | NICE recommends CYP2C19-ID Kit in final guidance | RNS |
| 15.07.2024 19:36 | CPI, VAST, ZED | EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises | Alliance |
| 15.07.2024 10:38 | GDR, VAST | AIM WINNERS & LOSERS: Destiny Pharma falls on plans to go private | Alliance |
| 15.07.2024 07:00 | GDR | Breakthrough Device Designation from the U.S. FDA | RNS |
| 27.06.2024 19:29 | TATE, GMS, ATG | EARNINGS AND TRADING: Fenikso in profit; Tate & Lyle completes sale | Alliance |
| 27.06.2024 09:28 | GDR | Short extension to NICE publication date | RNS |
| 25.06.2024 07:00 | GDR | Holding(s) in Company | RNS |
| 24.06.2024 11:13 | GDR | Holding(s) in Company | RNS |
| 24.06.2024 11:12 | GDR | Holding(s) in Company | RNS |
| 24.06.2024 11:11 | GDR | Holding(s) in Company | RNS |
| 17.06.2024 16:41 | GDR | Holding(s) in Company | RNS |
| 13.06.2024 15:22 | GDR | Holding(s) in Company | RNS |
| 11.06.2024 12:54 | GDR | Holding(s) in Company | RNS |
| 07.06.2024 11:00 | GDR | Holding(s) in Company | RNS |
| 05.06.2024 15:45 | GDR | Holding(s) in Company | RNS |
| 05.06.2024 11:39 | GDR | Holding(s) in Company | RNS |
| 31.05.2024 15:56 | GDR | Block listing returns | RNS |
| 31.05.2024 11:24 | GDR | Result of General Meeting | RNS |
| 30.05.2024 07:00 | GDR | Result of Open Offer and REX Offer | RNS |
| 24.05.2024 15:54 | PULS, OMU, GDR | UK shareholder meetings calendar - next 7 days | Alliance |
| 24.05.2024 11:31 | GDR | Genedrive announces orders for testing kit worth over GBP100,000 | Alliance |
| 24.05.2024 10:37 | GRL, GDR, KINO | AIM WINNERS & LOSERS: Kinovo rises as results ahead of expectations | Alliance |
| 24.05.2024 07:00 | GDR | Initial orders of the Genedrive MT-RNR1 Products | RNS |
| 21.05.2024 21:50 | GDR, PREM, TRB | TRADING UPDATES: CVS sells Dutch and Irish loss-making businesses | Alliance |
| 21.05.2024 11:00 | GDR | Key CYP2C19-ID test performance milestone achieved | RNS |
| 15.05.2024 07:00 | GDR | Amendment to Open Offer timetable | RNS |
| 14.05.2024 07:00 | GDR | Publication of Circular and Notice of GM | RNS |
| 10.05.2024 12:10 | GDR | IN BRIEF: Genedrive completes placing portion of GBP6 million raise | Alliance |
| 10.05.2024 10:59 | MTC, GDR, POLX | AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing | Alliance |
| 10.05.2024 07:00 | GDR | Completion of placing | RNS |
| 10.05.2024 07:00 | GDR | IN BRIEF: Genedrive aims to raise at least GBP6 million in share offer | Alliance |
| 09.05.2024 16:49 | GDR | Proposed REX Retail Offer | RNS |
| 09.05.2024 16:48 | GDR | Proposed Fundraise for a minimum of £6.0 million | RNS |
| 24.04.2024 17:26 | GDR | Genedrive enters clinical trial deal in US for MT-RNR1 US approval | Alliance |
| 24.04.2024 15:36 | GDR | Clinical Trial Agreement | RNS |
| 03.04.2024 17:00 | GDR | Application for Listing & Total Voting Rights | RNS |
| 03.04.2024 11:49 | GDR | Genedrive shares surge as UK's NICE backs test for ischaemic stroke | Alliance |
| 03.04.2024 10:47 | PEEL, CNS, GDR | AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal | Alliance |
| 03.04.2024 07:00 | GDR | NICE recommends the Genedrive CYP2C19-ID Kit | RNS |
| 28.03.2024 14:35 | GDR, SAAS, AXL | EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate | Alliance |
| 28.03.2024 07:00 | GDR | Half-year Report | RNS |
| 26.03.2024 07:00 | GDR | Investor presentation | Reach |
| 19.03.2024 15:53 | GDR | Application for Listing & Total Voting Rights | RNS |
| 15.03.2024 13:50 | GDR | Genedrive down as plans equity raise despite GBP800,000 tax credit | Alliance |
| 15.03.2024 12:30 | GDR | Receipt of R&D tax credit | RNS |
| 19.02.2024 18:57 | MOS, PHE, CORO | TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress | Alliance |
| 19.02.2024 07:00 | GDR | NICE Early Value Assessment update | RNS |
| 19.01.2024 16:14 | GDR | Total Voting Rights | RNS |
| 15.01.2024 15:21 | GDR | Total Voting Rights | RNS |
| 10.01.2024 07:00 | GDR | Total Voting Rights | RNS |
| 02.01.2024 10:57 | GDR | IN BRIEF: Genedrive draws down GBP600,000 on prepayment facility | Alliance |
| 02.01.2024 07:00 | GDR | Equity Prepayment Facility drawdown | RNS |
| 29.12.2023 11:44 | GDR | Result of AGM | RNS |
| 22.12.2023 15:50 | WBI, TFG, SBTX | UK shareholder meetings calendar - next 7 days | Alliance |
| 20.12.2023 16:57 | GDR | Total Voting Rights | RNS |
| 20.12.2023 11:07 | ANGS, GDR, VRS | AIM WINNERS & LOSERS: Genedrive shares jump on orders | Alliance |
| 20.12.2023 10:49 | GDR | IN BRIEF: Genedrive shares surge as six countries receive first orders | Alliance |
| 20.12.2023 07:00 | GDR | Initial overseas orders of MT-RNR1 ID kit | RNS |
| 07.12.2023 07:00 | GDR | Total Voting Rights | RNS |
| 06.12.2023 07:00 | GDR | Posting of annual report and notice of AGM | RNS |
